Literature DB >> 7370873

Appraisal of the World Health Organization classification of lung tumours.

J Jacques, D P Hill, K J Shier, A Jindani, A B Miller.   

Abstract

The 1967 World Health Organization (WHO) classification of the histologic types of lung tumours has been examined in relation to 303 tumours of patients admitted to a national trial of the treatment of lung cancer. In 63 instances (20%) there was disagreement between the diagnoses of the local pathologist and the reference pathologist. The slides for these 63 tumours were reviewed by two other pathologists, and the slides for 60 tumours for which there was agreement between the local and reference pathologists were reviewed by one of the other pathologists. The main disagreement was in the diagnosis of epidermoid (squamous) tumours. It is apparent that many pathologists do not adhere to the strict criterion of the presence of keratinization or intercellular prickles or both for the diagnosis of epidermoid carcinoma. In addition, there was substantial variation in the use of subtypes within the WHO classification. Use of the revised classification proposed by the WHO would have removed a small amount of the variation from these findings but would not have affected the main discrepancy. Stricter attention to the definition of types is required for a uniform approach to the histologic classification of lung tumours.

Entities:  

Mesh:

Year:  1980        PMID: 7370873      PMCID: PMC1801636     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  8 in total

1.  APPLICATION OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF LUNG CARCINOMA TO BIOPSY MATERIAL.

Authors:  R YESNER; B GERSTL; O AUERBACH
Journal:  Ann Thorac Surg       Date:  1965-01       Impact factor: 4.330

2.  An assessment of the World Health Organization classification of the histologic typing of lung tumors applied to biopsy and resected material.

Authors:  K F Hinson; A B Miller; R Tall
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

3.  Bronchiolo-alveolar carcinoma: a Clara cell tumor?

Authors:  J Jacques; W Currie
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

4.  A reappraisal of histopathology in lung cancer and correlation of cell types with antecedent cigarette smoking.

Authors:  R Yesner; N A Gelfman; A R Feinstein
Journal:  Am Rev Respir Dis       Date:  1973-05

5.  An attempt to use the WHO typing in the histological classification of lung carcinomas.

Authors:  A Reinilä; K Dammert
Journal:  Acta Pathol Microbiol Scand A       Date:  1974-11

6.  Observer variability in the histopathologic diagnosis of lung cancer.

Authors:  A R Feinstein; N A Gelfman; R Yesner
Journal:  Am Rev Respir Dis       Date:  1970-05

7.  Controversies in WHO tumour classification.

Authors:  L Kreyberg; W F Whimster
Journal:  Br Med J       Date:  1978-10-28

8.  Histological typing of lung cancer. Application of the World Health Organization classification to 479 cases.

Authors:  S Larsson; L Zettergren
Journal:  Acta Pathol Microbiol Scand A       Date:  1976-11
  8 in total
  6 in total

1.  NDRG1 attenuates epithelial-mesenchymal transition of nasopharyngeal cancer cells via blocking Smad2 signaling.

Authors:  Zhi-Yan Hu; Wei-Bing Xie; Fang Yang; Li-Wei Xiao; Xiao-Yan Wang; Shi-You Chen; Zu-Guo Li
Journal:  Biochim Biophys Acta       Date:  2015-06-10

2.  Collagen triple helix repeat containing 1 (Cthrc1) is an independently prognostic biomarker of non-small cell lung cancers with cigarette smoke.

Authors:  Xiaojun Liu; Beiyan Liu; Ying Cui; Fengping Wang; Hui Sun; Fuzhen Lv
Journal:  Tumour Biol       Date:  2014-08-21

3.  Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer.

Authors:  Gengpeng Lin; Longhua Sun; Ran Wang; Yubiao Guo; Canmao Xie
Journal:  J Thorac Oncol       Date:  2014-02       Impact factor: 15.609

4.  CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma.

Authors:  Longhua Sun; Lihong Bai; Gengpeng Lin; Ran Wang; Yangli Liu; Jinghuang Cai; Yubiao Guo; Zhiwen Zhu; Canmao Xie
Journal:  Oncotarget       Date:  2015-08-21

5.  Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway.

Authors:  Lihong Bai; Gengpeng Lin; Longhua Sun; Yangli Liu; Xinyan Huang; Chuangjie Cao; Yubiao Guo; Canmao Xie
Journal:  Oncotarget       Date:  2016-06-28

6.  The clinical significance of HPIP and the associated prognosis in cervical cancer.

Authors:  Fanling Meng; Haixia Liu; Shuang Liu; Rong Ma
Journal:  Oncotarget       Date:  2017-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.